The Shocking Truth About Vaccines

Berg argues that testing an active vaccine against another active vaccine, both containing immune-stimulating adjuvants, is analogous to comparing whiskey against bourbon to assess whiskey's safety. Both contain alcohol and cause similar toxicity, so by that comparison whiskey would appear 'safe.' He states that this study design clouds the entire 'safe and effective' assertion, because the baseline is not a neutral control. The justification that a true placebo would be unethical because it denies a child a potentially life-saving shot, according to Berg, collapses under scrutiny: without a true placebo, we simply cannot know the absolute risk profile of any single vaccine.

He emphasizes that this is not a minor methodological quibble—it is a structural feature of the vaccine approval process. The aluminum adjuvant is present in both arms, so any adverse reaction attributable to the adjuvant (or to the vaccine antigen combined with the adjuvant) is masked. Berg's frustration centers on the mismatch between the public's understanding of 'tested for safety' and the reality of the regulatory framework. He wants the audience to understand that 'safe and effective' cannot be tested rigorously under conditions where every subject receives an active immunostimulatory injection.

The deeper implication is that this design has been accepted as the gold standard, yet when someone questions it, they are branded as spreading medical misinformation, not for factual errors but for opposing medical consensus.

Berg contends that the raw data from research is not openly disseminated; pharma companies keep it confidential. When a study turns out poorly—perhaps showing little benefit or significant harm—the sponsor simply chooses not to publish it. The 87% figure he cites implies that the majority of clinical research is never seen by clinicians, patients, or policymakers. Consequently, health guidelines and medical practice are built on a foundation of selective disclosure.

He connects this to the 'safe and effective' narrative: how can the public trust the science when we can't get all of the science? Even a well-designed study, if its data remains locked away, cannot contribute to the balance of evidence. Berg’s point is that this isn’t just a transparency issue; it’s a structural corruption that skews the entire medical literature toward favorable results, making every drug look better than it is. Only when lawsuits force subpoenas does the full picture sometimes emerge, as in the case of Paxil, where litigation revealed hidden harms.

Berg points out that it's difficult to trace the flow of money between pharmaceutical companies and organizations like the WHO and CDC, but one concrete fact stands out: the CDC owns vaccine patents and gets royalties. This means the agency has a direct incentive to see those vaccines widely adopted and to protect their reputation. He frames this as a potential conflict of interest that is rarely discussed in mainstream health communication. Even if the scientists at the CDC are acting in good faith, the structural arrangement introduces a bias that the public deserves to know about.

The larger argument is that when institutions that define medical consensus have a financial stake in the products they endorse, dissenting voices are not just a nuisance—they are an essential check on self-dealing. Berg’s concern isn't that the science is intrinsically flawed, but that the people behind it have incentives that are not aligned with full transparency.

Berg opens the video by noting that science thrives on disagreement and that nearly every discovery came from contesting mainstream views. Yet, during the previous few years, anyone questioning vaccine policy was branded a spreader of medical misinformation—not because what they said was false, but because it contradicted the official position of institutions like the WHO and CDC. He argues that this redefinition suppresses the very debate that is essential to scientific progress.

The effect, he says, is that people who might have genuine, evidence-based concerns are silenced, and the public loses the ability to fully evaluate risks and benefits. By framing the debate as an ethics problem rather than a science problem, Berg shifts the focus from whether the data is correct to whether the system allows for honest examination of the data.